跳到正文

Akari Therapeutics Plc(AKTX)内部人交易:高管与董事近期交易

过去 18 个月,共有 7 位内部人为 Akari Therapeutics Plc(AKTX)报告了 44 笔 Form 4 交易(最近一笔 2026-11-19)。

日期内部人职务类型股数市值
2026-11-19Farag Kameel D.Interim CFO买入1,284$12,994
2026-11-19Farag Kameel D.Interim CFO买入1,589$12,998
2026-10-16Patel Sandip I董事买入4,313$34,068
2026-10-16Bazemore Robert B董事买入13,100$103,477
2026-10-16Prudo-Chlebosz Raymond董事买入9,072$71,660
2026-10-16Patel Samir Rashmikant董事买入6,300$49,764
2026-10-16Patel Sandip I董事买入12,100$95,578
2026-10-16Gaslightwala AbizerCEO买入19,333$8
2026-10-16Huh Hoyoung董事买入6,160$48,658
2026-10-16Bazemore Robert B董事买入4,677$36,944
2026-10-16Prudo-Chlebosz Raymond董事买入3,240$25,593
2026-10-16Patel Samir Rashmikant董事买入2,236$17,662
2026-10-16Huh Hoyoung董事买入17,249$136,250
2026-10-16Gaslightwala AbizerCEO买入7,733$3
2026-10-16Bazemore Robert B董事买入773$0
2026-10-16Patel Sandip I董事买入3,866$2
2026-10-16Bazemore Robert B董事买入3,093$1
2026-10-16Patel Sandip I董事买入6,186$2
2026-10-01Gaslightwala AbizerCEO买入6,430$62,500
2026-08-19Farag Kameel D.Interim CFO买入1,728$12,995
2026-08-05Farag Kameel D.Interim CFO买入1,130$12,995
2026-07-17Patel Samir Rashmikant董事买入1,209$9,672
2026-07-17Patel Samir Rashmikant董事买入15,466$0
2026-07-17Patel Samir Rashmikant董事买入5,799$0
2026-06-25Farag Kameel D.Interim CFO买入1,248$12,505

来源:SEC Form 4 申报文件 · 截至 2026-11-19